Alopecia Areata as an Immune-Related Adverse Event Associated with Response to Immune Checkpoint Inhibitors

July 2022 in “ European Journal of Dermatology ”

Rika Suzuki, Yukiko Kiniwa, Toshikazu Omodaka, Shiho Katsuie, Tatsuya Nihei, Ai Sato, Yuko Takazawa, Ryuhei Okuyama

We don't know much about this study yet.

We're maintaining the world's largest resposity of hair loss research. You can help out the community by sending a PDF of this study here . Not sure how to get a study's PDF? You can email the authors of the study.

View this study on pmc.ncbi.nlm.nih.gov →

Discuss this study in the Community →

Research cited in this study

3 / 3 results

research Nivolumab-Induced Alopecia Areata: A Case Report and Literature Review

10 citations , January 2021 in “Annals of dermatology/Annals of Dermatology”

Nivolumab can cause hair loss as a rare side effect.

research Hair Follicle Mesenchyme-Associated PD-L1 Regulates T-Cell Activation Induced Apoptosis: A Potential Mechanism of Immune Privilege

53 citations , September 2013 in “Journal of Investigative Dermatology”

Hair follicle cells help protect against immune attacks by regulating T-cell activity.

research Genome-Wide Association Study in Alopecia Areata Implicates Both Innate and Adaptive Immunity

717 citations , June 2010 in “Nature”

Alopecia areata involves both innate and adaptive immunity, with specific genes linked to the disease.

Related Research

1 / 1 results

research Twenty Nail Dystrophy with Alopecia Areata in an Atopic Child

April 2019 in “International journal of research in dermatology”

A child with rough nails also had hair loss and allergies.